Here is the honest state of the data: Obesity (Phase 2, randomized controlled trial): the landmark New England Journal of Medicine Phase 2 trial in obesity established both the once-weekly dosing and the escalation approach, and reported the largest average weight reductions seen for a once-weekly agent with the caveat that the reduction had not fully plateaued at 48 weeks
Safety, Side Effects & What to Watch For Peptides are generally well-tolerated most have mild side effect profiles compared to pharmaceuticals or hormones
Homocysteine is an inflammatory compound that can increase the risk of heart disease
Furthermore, moisture and humidity can accelerate hydrolysis, breaking down peptide bonds and leading to fragmentation
Each needle is 0.27mm long, just 1/7th the thickness of a hair , and is made from dissolvable medication
No clinical oversight Real prescribing involves screening for whether the medication is safe for you, given your medical history, and monitoring during dose increases